Drugs / PalloV-CC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03827967 | Jul 2019 → Apr 2023 | colon carcinoma | George E. Peoples | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PalloV-CC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03827967 ↗ |
| Modality | Vaccine | “The PalloV-CC vaccine uses yeast cell wall particles (YCWP) to serve as an efficient vaccine delivery system” NCT03827967 ↗ |